{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9NZQ7",
      "entity_text" : "PD-L1",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0665" ],
      "Cellular_component" : [ "go:GO:0043657" ],
      "CellType" : [ "cl:CL:0000738" ]
    }
  },
  "verbose_text" : "Further complicating matters, different companies have developed distinct companion assays for PD-L1 expression, each using different IHC antibodies, interpretations (expression on tumor cells, immune cells or both) and thresholds for positivity.",
  "reading_complete" : "2020-08-03T11:23:49Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T11:21:47Z",
  "trigger" : "expression",
  "evidence" : [ "PD-L1 expression" ],
  "pmc_id" : "6037030",
  "score" : 0
}